Presents:
Annual Meeting & Washington Update
The Dodd-Frank Act is causing a deluge of rulemaking at the various regulatory bodies that oversee our industry. The CFTC has been having weekly meetings regarding the various proposed regulations, with much attention being paid to speculative position limits and oversight of OTC products.
Read more